Introduction There is increasing evidence of excess mortality in schizophrenia but less
information on other non-affective psychoses. We therefore generated standardised …

ObjectivePrevalence of cardiovascular disease is high in schizophrenia. Our aim is to
estimate the prevalence of cardiovascular risk factors (CVRF) among schizophrenia …

Background People with schizophrenia and related disorders are at an increased risk of
adverse outcomes, including conviction of a violent offence, suicide, and premature …

OBJECTIVE: The aim of the study is to review the absolute and relative impacts of the major
causes for premature mortality among patients with schizophrenia. DATA SOURCES: We …

Background Numerous studies have investigated the relationship between schizophrenia
and the incidence of cardiovascular disease (CVD), but their results were not entirely …

AimsDecades of research show that people with schizophrenia have an increased risk of
death from cancer; however, the relationship between schizophrenia and cancer incidence …

Individuals with schizophrenia or substance use disorder have a substantially increased
mortality compared to the general population. Despite a high and probably increasing …

Introduction It has remained controversial if antipsychotic treatment is associated with
increased or decreased mortality among patients with schizophrenia, and if there are any …

BackgroundPrevious studies have reported conflicting results on the association between
schizophrenia and cancer mortality. AimsTo summarise available evidence and quantify the …

Over the last five years, large data sets on mortality in schizophrenia have been published
which have established mortality as a measurable clinical endpoint. Four issues need …